Case Detail

Pharmaceutical Research and Manufacturers of America v. Michigan Department of Community Health
On June 27, 2003, the Michigan Supreme Court declined to review a lower-court decision upholding a Michigan program that imposes price controls on pharmaceuticals sold to Medicaid recipients in the State. The decision was a setback for WLF, which filed a brief urging the court to review, and ultimately strike down, the program. WLF argued that the program is invalid because it conflicts with Michigan law and violates separation-of-power principles of the Michigan Constitution. WLF also argued that the program will mean substandard Medicare care for the State's poorest citizens, because it will result in their being denied access to essential drugs that the State has deemed too expensive.
Case Status:
Review denied.
More Information and Downloads:
2/5/2003: Download the Brief
4/4/2002: Download the Brief

  • Welcome to the Washington Legal Foundation
  • 2009 Massachusetts Ave., NW
    Washington, DC 20036
  • info@wlf.org  |  ph. 202-588-0302
    ©2018 WLF All Rights Reserved